Erik H Serné Selected Research

dapagliflozin

1/2022

Mechanisms underlying the blood pressure lowering effects of dapagliflozin, exenatide, and their combination in people with type 2 diabetes: a secondary analysis of a randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erik H Serné Research Topics

Disease

20	Insulin Resistance 01/2020 - 06/2004
12	Obesity 01/2022 - 11/2004
11	Type 2 Diabetes Mellitus (MODY) 02/2024 - 06/2011
10	Hyperinsulinism (Hyperinsulinemia) 01/2020 - 05/2002
8	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2023 - 08/2015
7	Hypertension (High Blood Pressure) 11/2013 - 11/2004
6	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 08/2011
5	Hyperemia 11/2011 - 05/2002
4	Hypoglycemia (Reactive Hypoglycemia) 01/2023 - 08/2015
4	Inflammation (Inflammations) 01/2019 - 12/2006
3	Arterial Occlusive Diseases (Arterial Occlusive Disease) 10/2011 - 06/2004
2	Overweight 10/2019 - 06/2015
2	Venous Thrombosis (Deep-Vein Thrombosis) 11/2018 - 01/2018
2	Necrosis 01/2015 - 03/2006
2	Neoplasms (Cancer) 01/2012 - 04/2010
2	Chronic Renal Insufficiency 01/2012 - 11/2011
1	Albuminuria 03/2024
1	Hip Osteoarthritis (Coxarthrosis) 02/2023
1	Kidney Diseases (Kidney Disease) 01/2023
1	Diabetes Complications 01/2023
1	Hypotension (Low Blood Pressure) 01/2021
1	Pulmonary Embolism 10/2020
1	Body Weight (Weight, Body) 01/2020
1	Weight Gain 01/2019
1	Cerebral Small Vessel Diseases 01/2019
1	Venous Thromboembolism 11/2018
1	Postthrombotic Syndrome 11/2018
1	Dementia (Dementias) 01/2018
1	Venous Insufficiency 01/2018
1	Cognitive Dysfunction 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Polyneuropathies (Polyneuropathy) 04/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2015
1	Abdominal Obesity 05/2015
1	Hypoxia (Hypoxemia) 05/2015
1	Atherosclerosis 01/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2012
1	Microvascular Rarefaction 11/2011

Drug/Important Bio-Agent (IBA)

22	Insulin (Novolin)FDA Link 01/2023 - 05/2002
20	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 01/2009
6	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2011 - 05/2002
6	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 11/2011 - 05/2002
4	Exenatide (Byetta)FDA Link 01/2022 - 06/2015
3	Blood Glucose (Blood Sugar)IBA 02/2024 - 10/2017
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2015 - 05/2002
2	LipidsIBA 01/2023 - 05/2015
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2018
2	Vasodilator Agents (Vasodilators)IBA 01/2019 - 01/2012
2	GoldIBA 11/2016 - 08/2015
2	AdipokinesIBA 07/2014 - 06/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012 - 04/2010
2	C-Reactive ProteinIBA 08/2011 - 12/2006
2	Nonesterified Fatty Acids (NEFA)IBA 01/2009 - 11/2004
2	SaltsIBA 04/2008 - 09/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2006 - 03/2006
1	HDL CholesterolIBA 03/2024
1	Metformin (Glucophage)FDA LinkGeneric 10/2023
1	SodiumIBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	dapagliflozinIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Troponin T (Troponin T1)IBA 10/2020
1	Growth Hormone (Somatotropin)IBA 01/2020
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2020
1	p-Aminohippuric Acid (p-Aminohippurate)FDA Link 10/2019
1	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 10/2019
1	Iloprost (Ventavis)FDA Link 11/2018
1	PolyphenolsIBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	NAD (NADH)IBA 04/2017
1	Glucagon-Like Peptides (Enteroglucagon)IBA 10/2016
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2016
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2016
1	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2016
1	AdiponectinIBA 03/2016
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 08/2015
1	Glucagon-Like Peptide-1 ReceptorIBA 06/2015
1	Transcription Factors (Transcription Factor)IBA 05/2015
1	Tumor Necrosis Factor InhibitorsIBA 01/2015
1	HomocysteineIBA 01/2014
1	Prednisolone (Predate)FDA LinkGeneric 11/2013
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 11/2013
1	ResistinIBA 11/2013
1	GlucocorticoidsIBA 11/2013
1	Angiogenesis InhibitorsIBA 01/2012
1	Bevacizumab (Avastin)FDA Link 01/2012
1	Docetaxel (Taxotere)FDA Link 01/2012
1	Bicarbonates (Hydrogen Carbonate)IBA 11/2011

Therapy/Procedure

7	Therapeutics 01/2023 - 01/2012
3	Lasers (Laser) 11/2011 - 07/2007
2	Injections 01/2022 - 11/2016
2	Duration of Therapy 11/2018 - 01/2018
1	Ambulatory Care (Outpatient Care) 03/2023
1	Knee Prosthesis 02/2023
1	Compression Stockings 01/2018
1	Glycemic Control 08/2015
1	Drug Therapy (Chemotherapy) 01/2012